tiprankstipranks
Trending News
More News >
Rama Phosphates Limited (IN:RAMAPHO)
:RAMAPHO
India Market

Rama Phosphates Limited (RAMAPHO) AI Stock Analysis

Compare
0 Followers

Top Page

IN:RAMAPHO

Rama Phosphates Limited

(RAMAPHO)

Select Model
Select Model
Select Model
Neutral 65 (OpenAI - 4o)
Rating:65Neutral
Price Target:
₹199.00
▲(29.18% Upside)
Rama Phosphates Limited has a solid financial performance with notable revenue growth and profitability improvements. Technical analysis supports a positive trend, although valuation metrics suggest the stock is fairly valued with a low dividend yield. The absence of earnings call data and corporate events does not impact the score.
Positive Factors
Revenue Growth
The company's strong revenue growth indicates a robust demand for its products, suggesting a solid market position and potential for continued expansion.
Improved Cash Flow
Positive free cash flow enhances liquidity, allowing for reinvestment in growth opportunities and providing a buffer against financial uncertainties.
Strengthened Equity Position
A stronger equity position indicates financial stability and resilience, providing a solid foundation for future growth and investment.
Negative Factors
Margin Volatility
Inconsistent margins can hinder profitability and affect long-term financial performance, necessitating improved cost management strategies.
Increasing Leverage
Rising leverage can strain financial resources and limit flexibility, posing risks if not managed effectively, especially in a competitive market.
Cash Management Discrepancies
Discrepancies in cash management can affect liquidity and operational efficiency, requiring better alignment of cash flows with earnings.

Rama Phosphates Limited (RAMAPHO) vs. iShares MSCI India ETF (INDA)

Rama Phosphates Limited Business Overview & Revenue Model

Company DescriptionRama Phosphates Limited engages in the manufacture and sale of fertilizers, chemicals, soya, and micronutrients in India. It operates through SSP Fertilizer, Chemicals, Power, Soya, and Micro Nutrients divisions. The company offers powder and granular single super phosphate fertilizers; various grades of nitrogen phosphorus potash mixed fertilizers; fortified fertilizers, such as boronated and zincated single super phosphate fertilizers; micronutrients, including magnesium sulphate, Sulphur dust, zinc sulphate, monohydrate, and zinc sulphate hepta-hydrate; and water soluble fertilizers. It also provides chemicals comprising sulphuric acid, oleum, and chlorosulphonic acid; and soya, lecithin, and de oiled cakes, as well as phospho gypsum and linear alkyl benzene sulphonic acid. Rama Phosphates Limited offers its products under the Girnar, Suryaphool, and Sampurn brand names. The company was incorporated in 1984 and is headquartered in Mumbai, India. As of 31 March 2022, Rama Phosphates Limited operates as a subsidiary of Silver Eagle Inc.
How the Company Makes MoneyRama Phosphates Limited generates revenue primarily through the sale of its fertilizers, particularly single super phosphate (SSP). The company's revenue model is built on direct sales to agricultural distributors and retailers, who then supply these products to end-users, including farmers. Key revenue streams include the volume of fertilizers sold, pricing strategies, and market demand fluctuations. Additionally, RAMAPHO may benefit from strategic partnerships with agricultural organizations and government initiatives aimed at promoting fertilizer use, which can enhance its market reach and sales. The company also focuses on optimizing production efficiency and cost management to maintain profitability in a competitive market.

Rama Phosphates Limited Financial Statement Overview

Summary
Rama Phosphates Limited shows promising growth potential with revenue and profitability improvements. However, challenges remain in maintaining consistent margins and managing increasing leverage. Continued focus on cash flow management and operational efficiency is crucial.
Income Statement
65
Positive
Rama Phosphates Limited has demonstrated significant revenue growth, particularly from 2024 to 2025, with a sharp increase in gross profit margins. However, the volatility in EBIT and net profit margins over the years indicates operational challenges. The transition from negative to positive net income is a notable improvement, but maintaining consistent profitability remains a challenge.
Balance Sheet
70
Positive
The company's equity position has strengthened over the years, showing a healthy equity ratio. However, the debt-to-equity ratio has increased, indicating growing leverage, which could pose a risk if not managed carefully. The stable growth in stockholders' equity is a positive indicator of financial health.
Cash Flow
60
Neutral
Free cash flow has improved significantly, turning positive in 2025 after a period of negative cash flows, which is a positive sign for liquidity. However, the operating cash flow to net income ratio indicates potential discrepancies in cash management. Efficient cash flow management will be crucial for sustaining growth.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue7.80B5.15B4.33B5.71B4.90B4.63B
Gross Profit2.50B2.23B-720.70M-975.08M-1.13B1.80B
EBITDA655.11M434.25M-207.22M722.57M1.14B624.07M
Net Income280.27M136.75M-310.67M409.34M700.37M421.09M
Balance Sheet
Total Assets0.006.34B6.26B5.34B4.43B3.11B
Cash, Cash Equivalents and Short-Term Investments36.69M36.69M73.65M62.42M17.57M8.72M
Total Debt0.001.26B1.49B1.18B588.47M54.98M
Total Liabilities-3.71B2.63B2.73B2.25B1.73B1.07B
Stockholders Equity3.71B3.71B3.53B3.09B2.70B2.04B
Cash Flow
Free Cash Flow0.00324.44M-131.67M-464.73M-429.47M254.41M
Operating Cash Flow0.00399.05M-51.04M-362.60M-85.82M444.56M
Investing Cash Flow0.00-41.33M-115.35M-81.45M-316.63M-212.70M
Financing Cash Flow0.00-358.86M164.22M447.50M402.07M-233.45M

Rama Phosphates Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price154.05
Price Trends
50DMA
176.31
Negative
100DMA
161.85
Negative
200DMA
137.63
Positive
Market Momentum
MACD
-7.19
Positive
RSI
40.81
Neutral
STOCH
40.01
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:RAMAPHO, the sentiment is Negative. The current price of 154.05 is below the 20-day moving average (MA) of 163.11, below the 50-day MA of 176.31, and above the 200-day MA of 137.63, indicating a neutral trend. The MACD of -7.19 indicates Positive momentum. The RSI at 40.81 is Neutral, neither overbought nor oversold. The STOCH value of 40.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:RAMAPHO.

Rama Phosphates Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
₹5.44B12.910.49%22.68%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
₹780.76M6.942.55%69.30%
58
Neutral
₹7.55B12.4067.43%
52
Neutral
₹2.90B29.877.61%-50.76%
45
Neutral
₹3.41B-5.22-1.30%-27.85%
44
Neutral
₹2.79B-11.21-100.00%-101.18%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:RAMAPHO
Rama Phosphates Limited
163.00
65.92
67.90%
IN:AGROPHOS
Agro Phos India Ltd.
39.26
-2.59
-6.19%
IN:KANORICHEM
Kanoria Chemicals & Industries Ltd
77.79
-38.16
-32.91%
IN:KHAICHEM
Khaitan Chemicals & Fertilizers Ltd.
81.92
11.38
16.13%
IN:NAGAFERT
Nagarjuna Fertilizers & Chemicals Ltd.
4.62
-4.94
-51.67%
IN:VIKASECO
Vikas EcoTech Limited
1.64
-1.60
-49.38%

Rama Phosphates Limited Corporate Events

Rama Phosphates Limited Releases Q2 FY26 Financial Performance
Oct 14, 2025

Rama Phosphates Limited has released its financial performance presentation for the quarter ended September 30, 2025. This announcement provides stakeholders with insights into the company’s financial health and operational progress, potentially impacting its market positioning and investor confidence.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 18, 2025